Do you have pustular psoriasis that mainly affects your hands and feet? You might be interested in a new treatment.
Do you have pustular psoriasis? Does it mainly affect your hands and feet? Would you like to take part in a trial of a new treatment?
Anakinra for Pustular psoriasis: Response in a Controlled Trial (APRICOT)
Pustular Psoriasis is a rare psoriasis subtype affecting 10% of psoriasis sufferers and it consistently ranks highest in terms of symptoms and functional impairment.
Unfortunately, treatment options are limited; those available often do not work or cause unacceptable side effects. To address this significant unmet need and to follow up on recent research a new trial known as APRICOT has been set up for patients with palmo-plantar pustulosis (PPP).
The trial, led by Professor Catherine Smith of Guy’s Hospital, London, and funded by the National Institute of Health Research and the Medical Research Council in partnership, is testing the licensed drug anakinra (Kineret®) over an 8 week period.
Prof Nick Reynold’s research team at the Royal Victoria Infirmary, Newcastle is running the trial and looking for potential participants. You can contact them directly on 01912 823568.
If you are interested in finding out more or would like to register your interest please click here to visit the trial website